Human Clinical Data The sole published human study examined 16 patients receiving intra-articular knee injections of 4mg BPC-157 for pain management
While comparison content can be useful from a research standpoint, the regulatory difference is important
Mark Hyman, MD Co-Founder and Chief Medical Officer, Function Health Sami Inkinen, M.Sci, MBA CEO & Founder, Virta Health Walking the GLP-1 Tightrope: Balancing expectations, outcomes and financial realities Join this panel of industry leaders as they dive into the complex questions surrounding GLP-1s today
Each procedure can be performed individually or combined into a single, comprehensive surgery to maximize transformation and minimize overall recovery time
Compare the numbers: What GLP-1 programs actually cost per month Roughly 30 million Americans use GLP-1 receptor agonists for weight management, yet insurance barriers remain a significant obstacle for many seeking treatment